NEURON BIO

Trading sesion


25/09/2017 Close

0.3000

Last price


4.68 mill. €

Capitalisation

11.11

Dif.(%)


-72.48

% Year 2017

Suspended 26/09/2017

Last Trade

Last

0.3000

Ref.

0.2700

Dif.(%)

11.11

Volume (Shares)

606,062

Turnover (€x1000)

180.87

Security

Security name

NEURON BIO

Ticker

NEU

ISIN

ES0166198012

NIF

A-18758300

Capital Admitted

15.611.366,00 Euros

Shares Admitted

15.611.366

Nominal

1 Euros

Trading

Continuo

Liquidity Provider

GVC Gaesco Beka, S.V., S.A.

Registered Advisor

GVC Gaesco Beka, S.V., S.A.

Auditor

DELOITTE, S.L

Address

CL/ AVICENA 4, 18016 GRANADA

Contact

accionistas@neuronbio.com

Historical Summary

 20132014201520162017 until 18/10

Capital Admitted (thousands of euros)

4,6256,9388,32512,65515,611

Shares (x 1,000)

4,6256,9388,32512,65515,611

Period Close Price (euros)

1.55002.30001.36001.09000.3000

Period Last Price (euros)

1.55002.30001.36001.09000.3000

Period High Price (euros)

2.40004.16003.28001.78001.1800

Period Low Price (euros)

1.09000.64001.29000.89000.1500

Capitalisation (thousands of euros)

7,16915,95611,32213,7944,683

Volume (thousands of shares)

1,00818,48615,04616,69922,566

Turnover (thousands of euros)

1,72241,44934,62119,88711,182

Company Profile

Neuron Bio (ticker: NEU) is the parent company of a group of R&D companies that develop research in two areas of biotechnology: the Biosanitary sector (Neuron Biolabs) and the Bioindustrial sector (Neol Bio).

Neuron Bio is listed in the Alternative Stock Market (ASM) in Spain.   

Neuron Biolabs develops biosolutions for application in the pharmaceutical and agri-food industries through its specialised divisions. The Pharma division is dedicated fundamentally to the search for preventative drugs and treatments for neurodegenerative diseases, particularly Alzheimer’s disease. The Diagnostic division develops tools and biomarkers for the diagnosis of diseases of the Central Nervous System, as in the case of Alzheimer’s. The Services Division offers a wide range of R&D services in the fields of biomedicine, toxicology and agri-food.   

Neol Bio (ticker: NEOL) is dedicated to the development of innovative biotechnological, industrial microbial processes for application in different sectors: functional food, oleochemistry, bioenergy and other bioproducts. These processes have been developed for clients and as internal R&D projects. Amongst the technologies that Neol Bio has developed is an exclusive platform for the production of high-value oils which has culminated in the creation of Neol Nutritional Products, a company dedicated to the production and commercialisation of high-quality Omega-3 DHA Oil with microalgae selected by Neol Bio

Relevant Facts and Notices

Significant participations

Financial Reports

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.

Copyright © Bolsas y Mercados Españoles 2017. All rights reserved. Disclaimer // Legal Disclaimer // Suppliers payment period